ARTICLE | Company News
Scios amends Natrecor NDA
January 10, 2001 8:00 AM UTC
SCIO filed an amendment to its 1998 NDA for Natrecor nesiritide recombinant B-type natriuretic peptide to treat acute congestive heart failure. In April 1999, the FDA asked for further data comparing ...